Literature DB >> 11433013

A sensitive, single-tube assay to measure the enzymatic activities of influenza RNA polymerase and other poly(A) polymerases: application to kinetic and inhibitor analysis.

L Hooker1, R Strong, R Adams, B Handa, J H Merrett, J A Martin, K Klumpp.   

Abstract

We describe a fast and robust new assay format to measure poly(A) polymerase (PAP) activity in a microtiter plate format. The new assay principle uses only natural nucleotide triphosphates and avoids a labour-intensive filtration step. A coupled enzymatic system combining PAP and reverse transcriptase forms the basis of the assay. The PAP generates a poly(A) tail on a RNA substrate and the reverse transcriptase is used to quantify the polyadenylated RNA by extension of a biotinylated oligo-dT primer. We demonstrate the principle of the assay using influenza virus RNA polymerase and yeast PAP as examples. A specific increase in the K(m) value for ATP and the observation of burst kinetics in the polyadenylation dependent, but not in the polyadenylation independent, assay suggest that a rate limiting step of influenza polymerase activity occurs after transcription elongation. Yeast PAP was used to validate the assay as an example of a template independent PAP. The new yeast PAP assay was approximately 100-fold more sensitive than the conventional TCA precipitation assay for yeast PAP, but the kinetic analysis of the PAP reaction gave similar results in both assays. The two enzymes show important differences with respect to inhibition by 3'-deoxy-ATP. Whereas the K(i) value for 3'-deoxy-ATP (105-117 microM) is similar to the K(m) value for ATP (186 microM) in the case of influenza RNA polymerase, the K(i) value for 3'-deoxy-ATP (0.4-0.6 microM) is approximately 100-fold lower than the K(m) value for ATP (50 microM) in the case of yeast PAP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433013      PMCID: PMC55778          DOI: 10.1093/nar/29.13.2691

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

Review 1.  The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?

Authors:  B Conne; A Stutz; J D Vassalli
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 2.  The ends of the affair: capping and polyadenylation.

Authors:  A J Shatkin; J L Manley
Journal:  Nat Struct Biol       Date:  2000-10

3.  A poly(A) polymerase from calf thymus. Purification and properities of the enzyme.

Authors:  M A Winters; M Edmonds
Journal:  J Biol Chem       Date:  1973-07-10       Impact factor: 5.157

4.  The influenza virus panhandle is involved in the initiation of transcription.

Authors:  E Fodor; D C Pritlove; G G Brownlee
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Mitochondrial poly(A) polymerase from a poorly differentiated hepatoma: purification and characteristics.

Authors:  K M Rose; H P Morris; S T Jacob
Journal:  Biochemistry       Date:  1975-03-11       Impact factor: 3.162

Review 6.  Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae.

Authors:  M Tucker; R Parker
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

7.  Influenza virus endoribonuclease.

Authors:  K Klumpp; L Hooker; B Handa
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

8.  Specific inhibition of chromatin-associated poly(A) synthesis in vitro by cordycepin 5'-triphosphate.

Authors:  K M Rose; L E Bell; S T Jacob
Journal:  Nature       Date:  1977-05-12       Impact factor: 49.962

9.  Effect of cordycepin triphosphate on the nuclear DNA-dependent RNA polymerases and poly(A) polymerase from the yeast, Saccharomyces cerevisiae.

Authors:  B Horowitz; B A Goldfinger; J Marmur
Journal:  Arch Biochem Biophys       Date:  1976-01       Impact factor: 4.013

10.  Transcription of the influenza ribonucleic acid genome by a virion polymerase. I. Optimal conditions for in vitro activity of the ribonucleic acid-dependent ribonucleic acid polymerase.

Authors:  D H Bishop; J F Obijeski; R W Simpson
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

View more
  5 in total

1.  Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.

Authors:  Brandi M Baughman; P Jake Slavish; Rebecca M DuBois; Vincent A Boyd; Stephen W White; Thomas R Webb
Journal:  ACS Chem Biol       Date:  2012-01-19       Impact factor: 5.100

Review 2.  New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.

Authors:  Grant Beyleveld; Kris M White; Juan Ayllon; Megan L Shaw
Journal:  Antiviral Res       Date:  2013-08-06       Impact factor: 5.970

Review 3.  Alternative Experimental Models for Studying Influenza Proteins, Host-Virus Interactions and Anti-Influenza Drugs.

Authors:  Sonja C J H Chua; Hui Qing Tan; David Engelberg; Lina H K Lim
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-30

4.  Investigation of Binding Affinity between Potential Antiviral Agents and PB2 Protein of Influenza A: Non-equilibrium Molecular Dynamics Simulation Approach.

Authors:  Tri Pham; Hoang Linh Nguyen; Tuyn Phan-Toai; Hung Nguyen
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

Review 5.  Advances in Development and Application of Influenza Vaccines.

Authors:  Jidang Chen; Jiehuang Wang; Jipei Zhang; Hinh Ly
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.